Hypertensive smokers have a worse cardiovascular risk profile than non‐smokers in spite of treatment – A national study in Sweden

References

• Kannel W, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens. 1990;8:3–5.
   PubMedGoogle Scholar
• Wilhelmsen L. Coronary heart disease: Epidemiology of smoking and intervention studies of smoking. Am Heart J. 1988;115:242–249.
   PubMed Web of Science ®Google Scholar
• Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med. 1986;314:271–275.
   Google Scholar
• Ezzati M, Lopez AD. Estimates of global mortality attribu-table to smoking in 2000. Lancet. 2003;362:847–852.
   PubMed Web of Science ®Google Scholar
• Khalili P, Nilsson PM, Nilsson j-A, Berglund G. Smoking as a modifier of the systolic blood pressure-induced risk of cardiovascular events and mortality: Population-based pro-spective study of middle-aged men. J Hypertens. 2002; 20:1759–1764.
   Google Scholar
• Kannel WB, McGee DL, Castelli WP. Latest perspective on cigarette smoking and cardiovascular disease: The Framingham study. J Cardiac Rehabil. 1984;4:267–277.
   Google Scholar
• MRC trial of treatment of mild hypertension: Principal results. Medical Research Council Working Party, BMJ. 1985;291:97–104.
   Google Scholar
• Zanchetti A, Hansson L, Clement D, Elmfeldt D, Julius S, Rosenthal T, et al. On behalf of the HOT Study Group. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: Does a J-shaped curve exist in smokers? J Hypertens. 2003;21:797–804.
   Google Scholar
• Dallongeville J, Marecaux N, Fruchart JC, Amouyel P. Cigarette smoking is associated with unhealthy patterns of nutrient intake: A meta-analysis. J Nutr. 1998;128: 1450–1457.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Lind L, Pollare T, Berne C, Lithe11 H. Increased level of glycosylated hemoglobin Al c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers compared to non-smokers. Metabolism. 1995;44:557–561.
   Google Scholar
• Rimm RE, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995;310:555–559.
   Google Scholar
• Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24: 1590–1595.
   Google Scholar
• Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: Evidence of a positive association from a large prospective cohort study. hit J Epidemiol. 2001;30:540–546.
   Google Scholar
• Lundman BM, Asplund K, Norberg A. Smoking and metabolic control in patients with insulin-dependent diabetes mellitus. J Internal Med. 1990;227:101–106.
   Google Scholar
• Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, et al. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care. 1996;9:43–47.
   Google Scholar
• Bangstad HJ, Osterby R, Rudberg S, Hartmann A, Brabrand K, Hanssen KF. Kidney function and glomerulo-pathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia. 2002;45:253–261.
   PubMedGoogle Scholar
• Baggio B, Budakovic A, Dalla Vestra M, Saller A, Bruseghin M, Fioretto P, et al. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol. 2002;13:2730–2736.
   PubMed Web of Science ®Google Scholar
• Ijzerman RG, Seme EH, Weissenbruch MM, Jongh RT, Stehouwer CD. Cigarette smoking is associated with an acute impairment of microvascular function in humans. Chin Sci (Lond). 2003;104:247–252.
   Google Scholar
• Nilsson P, Lundgren H, Söderström M, Fagerström K-0, Nilsson-Ehle P. Effects of smoking cessation on insulin and cardiovascular risk factors - a controlled study of 4 months' duration. J Intern Med. 1996;240: 189–194.
   Google Scholar
• Canga N, de Irala J, Vara E, Duaso MJ, Ferrer A, Martinez-Gonzales MA. Intervention study for smoking cessation in diabetic patients. A randomized controlled trial in both clinical and primary health care settings. Diabetes Care. 2000;23:1455–1460.
   Google Scholar
• Nilsson P, Andersson DKG, Andersson P-E, Schwan A, Ostlind B, Malmborg R, et al. Cardiovascular risk factors in treated hypertensives - a nation-wide, cross-sectional study in Sweden. J Internal Med. 1993;233:239–245.
   Google Scholar
• Cederholm J, Nilsson PM, Anderberg C-P, Fröberg L, Pettersson U for the Q-Heart Study Group. Blood pressure and other cardiovascular risk factors among treated hyper-tensives in Swedish primary health care. Scand J Prim Health Care. 2002;20:224–229.
   Google Scholar
• Wayne W. Daniel. Biostatistics: A foundation for analysis in the health sciences. 6th ed., New York: John Wiley & Sons, 1995.
   Google Scholar
• Douglas C . Montgomery. Design and analysis of experi-ments. 3th ed., New York: John Wiley & Sons, 1991.
   Google Scholar
• Eliasson B, Mero N, Taskinen M-R, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis. 1997;129:79–88.
   Google Scholar
• Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994;90:248–253.
   PubMed Web of Science ®Google Scholar
• Halkin H, Or J, Fuchs Z, Lusky A, Chetrit A, Modan M. Smoking accounts for adverse effect of antihypertensive medications on plasma lipids. A population-based study. Hypertension. 1989;14:210–217.
   Google Scholar
• Wachtell K, Olsen M H, Dahlöf B, Devereux RB, Kjeldsen SE, Niemenen MS, et al. Micmalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. J Hypertens. 2002;20:405–412.
   Google Scholar
• de Simone G, Devereux RB, Daniels SR, Meyer RA. Gender differences in left ventricular growth. Hypertension. 1995;26:979–983.
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol. 1993;72:310–313.
   Google Scholar
• Bella JN, Palmieri V, Wachtell K, Liu JE, Gerdts E, Nieminen MS, et al. Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: The LIFE study. J Human Hypertens. 2004;18:411–416.
   PubMedGoogle Scholar
• Writing Group for the Women's Health Initiatives Investigators, Risk and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiatives randomized controlled trial. JANIA. 2002;288:321–333.
   PubMedGoogle Scholar
• Verhave JC, Hillege HL, Burgerhof JG, Navis G, de Zeeuw D, and de Jong PE for the PREVEND study group. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol. 2003;14:1330–1335.
   Google Scholar
• Luchner A, Bröckel U, Muscholl M, Hense HW, Döring A, Rieggeret G, et al. Gender-specific differences of cardiac remodelling in subjects with left ventricular dysfunction: A population-based study. Cardiovasc Res. 2002;53:720–727.
   PubMedGoogle Scholar
• Omvik P. How smoking affects blood pressure. Blood Press. 1996;5:71–77.
   PubMedGoogle Scholar
• Szczech R, Hering D, Narkiewicz K. Smoking and cardio-vascular risk: New mechanisms and further evidence for a 'guilty' verdict. J Hypertens. 2004;22:31–34.
   Google Scholar
• Samuelsson 0, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, et al. Predictors of cardiovascular morbidity in treated hypertension: Results from the primary preventive trial in Goteborg, Sweden. J Hypertens. 1985;3: 167–176.
   Google Scholar
• Andersson OK, Almgren T, Persson B, Samuelsson 0, Hedner T, Wilhelmsen L. Survival in treated hyperten-sion: Follow up study after two decades. BMJ. 1998; 317:167–171.
   Google Scholar
• Zanchetti A, Hansson L, Dahlöf B, Elmfeldt D, Kjeldsen S, Kolloch R, et al. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens. 2001;19:1149–1159.
   Google Scholar
• Jeffrey E, Harris JE, Thun MJ, Mondul AM, Calle EE. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982–8. BMJ. 2004;328: 72.
   Google Scholar
• Kastarinen M, Tuomilehto J, Vartiainen E, Jousilahti P, Nissinen A, Puska P. Smoking trends in hypertensive and normotensive Finns during 1982-1997. J Hum Hypertens. 2002;16:299–303.
   PubMed Web of Science ®Google Scholar